CN1055014C - Medicine powder for curing hepatitis B - Google Patents
Medicine powder for curing hepatitis B Download PDFInfo
- Publication number
- CN1055014C CN1055014C CN97107483A CN97107483A CN1055014C CN 1055014 C CN1055014 C CN 1055014C CN 97107483 A CN97107483 A CN 97107483A CN 97107483 A CN97107483 A CN 97107483A CN 1055014 C CN1055014 C CN 1055014C
- Authority
- CN
- China
- Prior art keywords
- medicine
- hepatitis
- radix
- rhizoma
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 44
- 208000002672 hepatitis B Diseases 0.000 title claims abstract description 16
- 239000000843 powder Substances 0.000 title claims abstract description 9
- 229940079593 drug Drugs 0.000 title abstract description 3
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 241000222640 Polyporus Species 0.000 claims abstract description 9
- 241000190633 Cordyceps Species 0.000 claims abstract description 8
- 235000008216 herbs Nutrition 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 239000010231 banlangen Substances 0.000 claims description 8
- 241000700721 Hepatitis B virus Species 0.000 abstract description 11
- 239000006187 pill Substances 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 2
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 241000157511 Oldenlandia Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000000311 effect on hepatitis Effects 0.000 abstract 1
- 238000003672 processing method Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 22
- 210000004185 liver Anatomy 0.000 description 12
- 208000006454 hepatitis Diseases 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 206010008909 Chronic Hepatitis Diseases 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 241000700605 Viruses Species 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 206010019847 hepatosplenomegaly Diseases 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 229920002527 Glycogen Polymers 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 238000007449 liver function test Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000029812 viral genome replication Effects 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229960003636 vidarabine Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for treating hepatitis B, namely powder for detoxifying hepatitis B viruses and converting hepatitis B viruses into negative, which belongs to the field of medicines. The medicine is a patent medicine in powder or pills prepared by a traditional processing method according to proportion quantity by using the following traditional Chinese medicine materials: astragalus root, cordycep, white atractylodes rhizome, red peony root, ganoderma, smilacis glabrae, polyporus, oldenlandia, giant knotweed, rhubarb, isatis root and schisandra fruit. The medicine has obvious curative effect on hepatitis B and hepatitis B virus carriers.
Description
The present invention relates to a kind of medicine medicine powder for curing hepatitis B for the treatment of hepatitis B, is the patent medicine made from conventional method with Chinese medicinal herbs, belongs to field of medicaments.
At present, the medicine of treatment hepatitis B is a lot, as the interferon of Western medicine, vidarabine, acycloguanosine etc., and its negative conversion rate 19-39%, and cost an arm and a leg, side effect is big, and curative effect is not consolidated.Traditional dialectical executing controlled, though used medicine can improve clinical symptoms preferably, but inhibition hepatitis B virus, promote the virus marker thing to turn out cloudy undesirable, belong to mitigate the disease, and be difficult to clinical cure, select virus is had the Chinese medicine preparation of certain effect, but being difficult to adapt to the global feature that the hepatitis B course of disease is touching, syndrome simulataneous insufficiency and excessive is complicated and changeable, curative effect is not very good.
Purpose of the present invention just is: invent a kind of comparatively ideal medicine medicine powder for curing hepatitis B made from Chinese medicinal herbs of treatment hepatitis B.
The present invention reaches its purpose like this: the patent medicine that this Department of Pharmacy makes with Chinese medicinal herbs, and the component proportional quantity (in gram) in component and the former medicine of per 98 grams thereof is:
Radix Astragali 4-16, Cordyceps 2-8, Ganoderma 6-10, Rhizoma Atractylodis Macrocephalae 4-8, Radix Paeoniae Rubra
6-10, Rhizoma Smilacis Glabrae 8-14, Polyporus 4-12, Herba Hedyotidis Diffusae 4-20,
Rhizoma Polygoni Cuspidati 5-16, Radix Isatidis 6-14, Radix Et Rhizoma Rhei 1-6, Fructus Schisandrae Chinensis 3-9.
Further specified below in conjunction with embodiment, but be not limited only to this.
Embodiment one:
1, the component of medicine and proportional quantity thereof.The patent medicine that this Department of Pharmacy makes with Chinese medicinal herbs, the proportional quantity (in gram) of each component is in the former medicine of its per 98 grams:
The Radix Astragali 16, Cordyceps 8, Ganoderma 6, the Rhizoma Atractylodis Macrocephalae 4, Radix Paeoniae Rubra 6, Rhizoma Smilacis Glabrae 8, Polyporus 4, Herba Hedyotidis Diffusae 20, Rhizoma Polygoni Cuspidati 16, Radix Isatidis 6, Radix Et Rhizoma Rhei 1, Fructus Schisandrae Chinensis 3.
2, the manufacture method of medicine.Can be processed into powder or pill etc. by the Chinese patent medicine conventional method.Chinese medicinal herbs is dried (i.e. Chang Gui dried Chinese medicinal herbs), presses proportional quantity metering, be processed as the end, be mixed by per 6 gram packs with medicinal material pulverizer, powder.If make pill, can in mixing the end, add suitable quantity of water (well water or tap water), make granulous pill with granulating machine, to dry, per 6 gram packs get final product.Produce in enormous quantities, can enlarge metering in above-mentioned component ratio and get final product.
3, drug administration method and preservation.For oral administration, day clothes three times, each 6 grams, 20 is a course of treatment, serve on two courses of treatment and imitates good.Place shady and cool dry place to preserve.
4, clinical effectiveness.To 118 routine acute and chronic hepatitis ies, hepatitis B virus the healthy carrier treat with this medicine, after two courses of treatment, conducts a survey 86 examples of wherein fully recovering, produce effects 28 examples, invalid 4 examples, total effective rate 96.6%.The toxic and side effects reaction is not found in clinical trial.
Recovery from illness refers to: subjective symptoms disappears, and hepatosplenomegaly is stablized constant or retraction, and the hepatic region does not have tenderness and kowtows pain, and liver function test recovers normal, and the virus replication index disappears, and the still sustainable existence of HBSAG, and above index was stablized more than 1 year.Produce effects refers to: cardinal symptom disappears or significantly alleviates, and hepatosplenomegaly no change, hepatic region do not have obvious tenderness and kowtow pain, and liver function test recovers normal or slight abnormality, and the virus replication index level reduces.Invalid finger: subjective symptoms, liver function index all do not recover to take a turn for the better.
Embodiment two:
1, medicine components and proportional quantity thereof.The patent medicine that this Department of Pharmacy processes with Chinese medicinal herbs, the component proportional quantity (in gram) in the former medicine of its per 98 grams is:
The Radix Astragali 10, Cordyceps 4, Ganoderma 8, the Rhizoma Atractylodis Macrocephalae 6, Radix Paeoniae Rubra 8, Rhizoma Smilacis Glabrae 10, Polyporus 8, Herba Hedyotidis Diffusae 12, Rhizoma Polygoni Cuspidati 10, Radix Isatidis 12, Radix Et Rhizoma Rhei 4, Fructus Schisandrae Chinensis 6.
2, manufacture method of medicine, instructions of taking, preservation are with example one.
3, clinical effectiveness.To 128 routine acute and chronic hepatitis ies, hepatitis B virus healthy carrier treatment, after two courses of treatment, conduct a survey 96 examples of wherein fully recovering, invalid 3 examples of produce effects 29 examples, total effective rate 97.6%.Clinical observation finds no the toxic and side effects reaction.All the other are with example one.
Embodiment three:
1, medicine components and proportional quantity thereof.This medicine is made patent medicine with Chinese medicinal herbs, and the component proportional quantity (in gram) in the former medicine of its per 98 grams is: the Radix Astragali 4, Cordyceps 2, Ganoderma 10, the Rhizoma Atractylodis Macrocephalae 8, Radix Paeoniae Rubra 10, Rhizoma Smilacis Glabrae 14, Polyporus 12, Herba Hedyotidis Diffusae 4, Rhizoma Polygoni Cuspidati 5, Radix Isatidis 14, Radix Et Rhizoma Rhei 6, Fructus Schisandrae Chinensis 9.
2, manufacture method of medicine, instructions of taking, preservation are with example one.
3, clinical effectiveness.96 routine acute and chronic hepatitis ies, hepatitis B virus healthy carrier are treated, after two courses of treatment, conduct a survey, 65 examples of wherein fully recovering, produce effects 27 examples, invalid 4 examples, total effective rate 95.8%.Clinical trial is not found the human body toxic side effect is reacted.All the other are with example one.
Pharmacology and resultant effect analysis.Hepatitis B, from traditional Chinese medical science angle, for damp and hot evil poison pents up, QI and blood stasis, cause disorder of QI and blood, liver,spleen,kidney loses, and becomes the card of simulataneous insufficiency and excessive, should consider alternately to occur damp-heat accumulation, deficiency of spleen-YANG and kidneyYANG on Drug therapy, the hepatic and renal YIN deficiency, the wet resistance of QI and blood, qi depressions to blood stasis etc. are carried out dialectical executing and are controlled.This medicine is exactly from then on to set out, and develops, and wherein the Radix Astragali has tonifying Qi and lifting yang, row is stagnant improves blood circulation and nutriture, the enhancing human body immunity function, and the liver protecting, recovery liver function prevent the effect that liver glycogen reduces; Cordyceps has nourishing YIN Yiyang, strengthens immune function of human body, antibiotic, antineoplastic action; The Ganoderma depressed liver-energy dispersing and QI regulating, raise immunity, hepatitis B virus goes out; Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI, dampness diuretic, antitumor, the liver protecting; Radix Paeoniae Rubra is returned Liver Channel, and clearing away heat and cooling blood is arranged, eliminating stasis to stop pain, and the effect of fire is let out in liver heat removing; Rhizoma Smilacis Glabrae is returned the stomach Liver Channel, and the germ-resistant effect of removing dampness and detoxicating is arranged; Polyporus has promoting diuresis to eliminate damp pathogen, the effect of antibiotic, antitumor; Herba Hedyotidis Diffusae has heat-clearing and toxic substances removing, eliminating damp-heat, the effect of anti-inflammation curing oncoma; Radix Et Rhizoma Rhei is returned liver taste large intestine channel, and purging heat and dredging bowels is arranged, removing pathogenic heat from blood and toxic substance from the body, clots absorbing removing mass, spasmolytic function of gallbladder promoting, the effect of antibiotic, antiviral, antitumor; Rhizoma Polygoni Cuspidati has the merit of expelling wind and removing dampness, dissipating blood stasis to promote menstruationg, toxin expelling, pain relieving; Fructus Schisandrae Chinensis has the liver protecting, and excited maincenter promotes liver glycogen to decompose, and reduces the effect of glutamate pyruvate transaminase, can strengthen the defence capability of antibody to nonspecific stimulation; Radix Isatidis has heat-clearing and toxic substances removing, antiviral effect.More than all medical materials by above-mentioned dosage; synergism; the Fructus Schisandrae Chinensis transaminase lowering, the wadding the turbid descending falls in Rhizoma Smilacis Glabrae, Rhizoma Polygoni Cuspidati, and icteric index falls in Radix Isatidis; the Radix Astragali, Rhizoma Atractylodis Macrocephalae rising serum albumin; Ganoderma, the soft hepatosplenomegaly that contracts of Polyporus, the liver protecting promotes liver cell regeneration; Radix Et Rhizoma Rhei, Rhizoma Polygoni Cuspidati, Radix Isatidis suppress hepatitis virus, and the Radix Astragali, Ganoderma, Herba Hedyotidis Diffusae, Polyporus, the Rhizoma Atractylodis Macrocephalae, Fructus Schisandrae Chinensis, Cordyceps, Radix Paeoniae Rubra play raise immunity.Therefore, this medicine has heat-clearing and toxic substances removing, soothing the liver dampness removing, QI invigorating resolving depression, nourishing yin and activating blood, can improve immune function of human body rapidly, kill hepatitis B virus, remove the hepatitis B antigen positive, make the negative conversion rate height, improve the hepatic pathology state, promote liver cell regeneration, recover liver function, to the treatment hepatitis B, hepatitis B virus health is carried the patient that significant curative effect is arranged.In the above-mentioned example, 342 routine acute and chronic hepatitis ies, hepatitis B virus healthy carrier are carried out clinical trial; After two courses of treatment, check, 247 examples of wherein fully recovering, produce effects 84 examples, invalid 11 examples, average total effective rate reaches 96.7%, and is evident in efficacy.Clinical observation, safe and reliable to patient's human body, do not find the toxic and side effects reaction.This medicine is inexpensive, is the ideal medicament of treatment hepatitis B.
Claims (1)
1, a kind of medicine medicine powder for curing hepatitis B for the treatment of hepatitis B is the patent medicine made from Chinese medicinal herbs, it is characterized in that: the proportional quantity (in gram) of each component is in the component of this medicine and the former medicine of per 98 grams thereof:
Radix Astragali 4-16, Cordyceps 2-8, Ganoderma 6-10, Rhizoma Atractylodis Macrocephalae 4-8,
Radix Paeoniae Rubra 6-10, Rhizoma Smilacis Glabrae 8-14, Polyporus 4-12, Herba Hedyotidis Diffusae 4-20,
Rhizoma Polygoni Cuspidati 5-16, Radix Isatidis 6-14, Radix Et Rhizoma Rhei 1-6, Fructus Schisandrae Chinensis 3-9.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97107483A CN1055014C (en) | 1997-05-05 | 1997-05-05 | Medicine powder for curing hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97107483A CN1055014C (en) | 1997-05-05 | 1997-05-05 | Medicine powder for curing hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1163143A CN1163143A (en) | 1997-10-29 |
| CN1055014C true CN1055014C (en) | 2000-08-02 |
Family
ID=5169597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97107483A Expired - Fee Related CN1055014C (en) | 1997-05-05 | 1997-05-05 | Medicine powder for curing hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1055014C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100387271C (en) * | 2004-07-26 | 2008-05-14 | 高广法 | Medicine for treating hepatitis B |
| CN101966234B (en) * | 2009-07-27 | 2011-12-21 | 王法根 | Medicament capable of eliminating hepatitis B virus (HBV) |
| CN111643617A (en) * | 2020-07-07 | 2020-09-11 | 常德市永春堂生物科技有限公司 | Traditional Chinese medicine composition for conditioning and treating liver diseases and preparation method thereof |
-
1997
- 1997-05-05 CN CN97107483A patent/CN1055014C/en not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| 《中医药学报》1993,(4) 1993.4.30 何明景，扶正化湿解毒方治疗慢性乙型肝炎对HBV血清学改变的观察 * |
| 《四川中医》1887,(3) 1987.3.30 李玉银，乙肝煎治疗乙型肝炎25例 * |
| 《四川中医》1887,(3) 1987.3.30 李玉银，乙肝煎治疗乙型肝炎25例;《中医药学报》1993,(4) 1993.4.30 何明景，扶正化湿解毒方治疗慢性乙型肝炎对HBV血清学改变的观察 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1163143A (en) | 1997-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463528B (en) | Traditional Chinese medicine composition for treating chronic eczema | |
| CN1103223C (en) | Chinese medicine for treating cholecystitis | |
| CN1055014C (en) | Medicine powder for curing hepatitis B | |
| CN1056755C (en) | Medicine of curing hepatitis | |
| CN1413606A (en) | Medicine for treatment of hepatitis | |
| CN1150926C (en) | Medicine for treating hepatism | |
| CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
| CN1493315A (en) | Medicine for treating chronic hepatitis B | |
| CN1298724A (en) | Medicine for treating immunodefiiciency disease | |
| CN101199749A (en) | Chinese medicine for treating AIDS | |
| CN1164294C (en) | Liver cancer resisting medicine | |
| CN1136899C (en) | Chinese medicine for treating mastoplasia | |
| CN1050045C (en) | Traditional Chinese medicine-Liu's Hua'ai huixiangdan for treating carcinoma of esophagus | |
| CN1583073A (en) | Chinese patent medicinal prescription for catch-cold | |
| CN1164318C (en) | Capsule for treating gynaecological inflammation | |
| CN1088589C (en) | Chinese medicine | |
| CN1061249C (en) | Quick-acting traditional Chinese medicine for curing hepatitis B | |
| CN1058622C (en) | Rehabilitation powder for hepatitis B | |
| CN1340353A (en) | Orally-applied medicine for treating hepatism and its preparing process | |
| CN1062844A (en) | Prevent and treat the preparation method of AIDS Chinese medicinal formulae | |
| CN1209131C (en) | Medicine 'Yiganjiangmeisan' for treating hepatitis B and its preparing process | |
| CN1092970C (en) | Compound Chinese medicine for treating hepatocholepathy | |
| CN1116893C (en) | Preparation for treating child virus diarrhea | |
| CN101194997A (en) | Chinese medicine preparation for treating AIDS method for preparing the same | |
| CN1086949C (en) | Chinese medicine for hepatitis B and its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |